Related Experiment Video
Updated: Jun 7, 2026
09:16
Use of a Wireless Video-EEG System to Monitor Epileptiform Discharges Following Lateral Fluid-Percussion Induced Traumatic Brain Injury
Published on: June 21, 2019
Statin use and risk of epilepsy: a nested case-control study
Mahyar Etminan1, Ali Samii, James M Brophy
1Center for Clinical Epidemiology and Evaluation, Vancouver Coastal Health Research Institute, Canada. mahyar.etminan@vch.ca
Neurology
|October 27, 2010
Summary
Hydroxymethyl-glutaryl-coenzyme A reductase inhibitors (statins) may reduce the risk of epilepsy hospitalization. This population-based study found a lower rate of epilepsy among current statin users compared to non-users.
Area of Science:
- Neurology
- Pharmacology
- Epidemiology
Background:
- Epilepsy is a chronic neurological disorder affecting millions worldwide.
- Statins are widely prescribed for cardiovascular disease prevention.
- The potential neuroprotective effects of statins are an area of ongoing research.
Purpose of the Study:
- To investigate the association between statin use and the risk of epilepsy.
- To determine if statins have a preventative effect against epilepsy hospitalization.
Main Methods:
- Population-based, nested case-control study in Quebec, Canada.
- Cohort of 150,555 cardiovascular patients who underwent revascularization.
- 217 epilepsy cases matched with 2,170 controls; adjusted for confounders using logistic regression and propensity score matching.
Main Results:
- Current statin users showed a significantly reduced rate ratio for epilepsy (0.65; 95% CI 0.46-0.92).
- Past statin use showed a non-significant trend towards reduced epilepsy risk (0.72; 95% CI 0.39-1.30).
- Control drug groups (non-statin cholesterol-lowering, beta-blockers, ACE inhibitors) showed no association with epilepsy risk.
Conclusions:
- Statin use is associated with a decreased risk of hospitalization for epilepsy in older adults.
- These findings suggest a potential preventative role for statins in epilepsy.
- Further research is needed to confirm these observational findings due to the study's nature.
Related Concept Videos
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:22Epilepsy ll: Types
Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
01:13Seizures: Classification
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
01:14Antiepileptic Drugs: Glutamate Antagonists
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
01:17Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...